Fundraising Fox

Truffle Capital

Venture capital

Paris · Seed–Growth · 2 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Truffle Capital focuses on creating, financing, and developing technology leaders in two core areas: BioMedTech and Finance/Insurance technology. The firm takes a hands-on approach, frequently acting as a founder in biomedtech ventures and serving as lead investor in financing rounds while actively participating in governance. With over two decades of experience, Truffle aims to support companies on their path to becoming industry leaders.

Source: firm website, verified Jul 21, 2026.

Stage
Seed–Growth
Check
$5.5M – $16.5M
HQ
Paris, FR
Leads rounds
Leads
Instruments
Equity
Founded
2001
AUM
$555M

Team · 2 people

from the firm's website
Henri Moulard· Chairman & Co-Founder

Chairman and former CEO of Generali, and former chairman of Banque Neuflize ABN Amro France. He holds the rank of Officer of the Légion d'Honneur.

Philippe Pouletty· CEO and Co-Founder

Physician and serial entrepreneur who founded Abivax and Carvolix, holds 39 patents, and is a major in immunology from the Pasteur Institute. He is a member of the Stanford Inventor Hall of Fame.

Frequently asked questions

What stage does Truffle Capital invest at?
Truffle Capital invests at the Seed, Series A, Series B, Series C, Growth stages.
What is Truffle Capital's typical check size?
Truffle Capital typically writes checks of $5.5M – $16.5M.
What sectors does Truffle Capital focus on?
Truffle Capital focuses on AI & Machine Learning, Biotech, Cybersecurity, Deep Tech, Fintech, InsurTech, Medical Devices.
Where is Truffle Capital located?
Truffle Capital is headquartered in Paris, FR.
Does Truffle Capital lead rounds?
Yes, Truffle Capital leads investment rounds.

Images

Truffle Capital photo

Similar investors

Featured in lists